Royal Bank of Canada
ZLAB icon

Royal Bank of Canada’s Zai Lab ZLAB Stock Holding History

Royal Bank of Canada’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Sell
1,697
-44
-3% -$869 ﹤0.01% 6047
2026
Q1 		$33K Sell
1,741
-13,016
-88% -$241K ﹤0.01% 5683
2025
Q4 		$260K Sell
14,757
-6,614
-31% -$155K ﹤0.01% 4607
2025
Q3 		$724K Buy
21,371
+2,664
+14% +$91.7K ﹤0.01% 4221
2025
Q2 		$655K Buy
18,707
+4,936
+36% +$162K ﹤0.01% 4262
2025
Q1 		$498K Buy
13,771
+9,390
+214% +$289K ﹤0.01% 4012
2024
Q4 		$115K Buy
4,381
+2,830
+182% +$78.6K ﹤0.01% 5251
2024
Q3 		$38K Sell
1,551
-86
-5% -$1.63K ﹤0.01% 5830
2024
Q2 		$29K Sell
1,637
-135
-8% -$2.37K ﹤0.01% 5914
2024
Q1 		$29K Sell
1,772
-1,471
-45% -$31K ﹤0.01% 5762
2023
Q4 		$88K Sell
3,243
-1,257
-28% -$33.2K ﹤0.01% 5695
2023
Q3 		$109K Sell
4,500
-352
-7% -$9.37K ﹤0.01% 5330
2023
Q2 		$135K Buy
4,852
+4,613
+1,930% +$151K ﹤0.01% 5090
2023
Q1 		$8K Sell
239
-393
-62% -$15.1K ﹤0.01% 6428
2022
Q4 		$19K Buy
632
+584
+1,217% +$18.4K ﹤0.01% 6333
2022
Q3 		$1K Buy
48
+43
+860% +$1.84K ﹤0.01% 7298
2022
Q2 		$0 Hold
5
– – ﹤0.01% 7774
2022
Q1 		$0 Sell
5
-126
-96% -$6.09K ﹤0.01% 8076
2021
Q4 		$8K Buy
131
+116
+773% +$9.84K ﹤0.01% 7127
2021
Q3 		$2K Sell
15
-10,025
-100% -$1.44M ﹤0.01% 7372
2021
Q2 		$1.78M Buy
10,040
+4,460
+80% +$717K ﹤0.01% 3169
2021
Q1 		$745K Sell
5,580
-1,758
-24% -$272K ﹤0.01% 3845
2020
Q4 		$993K Buy
7,338
+1,023
+16% +$104K ﹤0.01% 3489
2020
Q3 		$525K Buy
6,315
+6,190
+4,952% +$497K ﹤0.01% 3809
2020
Q2 		$10K Sell
125
-950
-88% -$64.3K ﹤0.01% 5844
2020
Q1 		$55K Buy
1,075
+1,061
+7,579% +$55.3K ﹤0.01% 5107
2019
Q4 		$1K Buy
+14
New +$517 ﹤0.01% 6700
2019
Q2 		– Sell
-140
Closed -$4K – 7251
2019
Q1 		$4K Buy
+140
New +$3.83K ﹤0.01% 6370
2018
Q4 		– Sell
-49
Closed -$1K – 7168
2018
Q3 		$1K Buy
+49
New +$1.06K ﹤0.01% 6628

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada's ZLAB Position: Q2 2026 in Review

Royal Bank of Canada reduced its Zai Lab (ZLAB) stake by 2.5% in Q2 2026, selling an estimated $869 and leaving 1,697 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #6047.

Royal Bank of Canada first reported a position in ZLAB in Q3 2018 and has held it in 29 quarters since. The position peaked at $1.78M in Q2 2021. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Royal Bank of Canada held 1,697 shares of Zai Lab worth $32K as of Q2 2026.
  • Royal Bank of Canada sold 44 Zai Lab shares in Q2 2026, an estimated $869.
  • Zai Lab made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6047 holding.
  • Royal Bank of Canada first reported a position in Zai Lab in Q3 2018 and has held it in 29 quarters since.
  • Royal Bank of Canada's Zai Lab position peaked at $1.78M in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.